Provider Communicator Summer 2018
This is a newsletter article. The information may not be up-to-date. If you have questions, please contact your Provider Coordinator.

SHINGRIX- New​ Shingles Vaccine

A new vaccine is now recommended for the prevention of shingles (herpes zoster). This vaccine is SHINGRIX® (zoster vaccine recombinant, adjuvanted). It should be given to adults aged 50 and older who are not immunocompromised (i.e. do not have a suppressed immune system).

SHINGRIX is given as two injections, with the second injection given between two to six months after the first.

This vaccine is preferred over the previous zoster vaccine, ZOSTAVAX. If patients were previously vaccinated with ZOSTAVAX, they should also now receive SHINGRIX.

Be aware that there is a current shortage of SHINGRIX, so it may be difficult to obtain. Many pharmacies that provide immunizations offer the shingles vaccines; however, for Quartz commercial members, this immunization would not be covered in the pharmacy, and should be given in the doctor’s office instead.

Shingrix is covered under Medicare Part D, available directly from a pharmacy and this is generally the most cost-effective way for members with Medicare coverage to receive this vaccine.

​Updated Immunization Schedules

In October 2017, the Advisory Committee on Immunization Practices (ACIP) voted to approve the following recommended immunization schedules –

View the new immunization schedules now.